Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


April 18, 2015 12:14 AM ET

Healthcare Equipment and Supplies

Company Overview of BioSig Technologies, Inc.

Company Overview

BioSig Technologies, Inc., a development stage medical device company, engages in developing technology platform to minimize noise and artifacts from cardiac recordings during electrophysiology studies. Its product under development includes PURE (Precise Uninterrupted Real-time evaluation of Electrograms) EP system, a surface electrocardiogram and intracardiac multichannel recording and analysis system that acquires, processes, and displays electrocardiogram and electrograms required during electrophysiology studies and ablation procedures. The company is also developing a library of software tools that are designed to be configured to fit the needs of electrophysiologists in various settin...

12424 Wilshire Boulevard

Suite 745

Los Angeles, CA 90025

United States

Founded in 2009

8 Employees

Phone:

310-820-8100

Key Executives for BioSig Technologies, Inc.

Chief Executive Officer, President and Director
Age: 57
Total Annual Compensation: $103.1K
Co-Founder and Executive Chairman
Age: 46
Total Annual Compensation: $206.9K
Chief Financial Officer
Age: 60
Total Annual Compensation: $49.5K
Compensation as of Fiscal Year 2014.

BioSig Technologies, Inc. Key Developments

BioSig Technologies Appoints Jerome B. Zeldis to the Board of Directors

BioSig Technologies announced that Dr. Jerome B. Zeldis has joined the Company's Board of Directors, effective immediately. Dr. Zeldis has agreed to chair the Nominating Committee at the next regularly scheduled Board meeting. He is currently Chief Executive Officer of Celgene Global Health and Chief Medical Officer of Celgene Corporation.

BioSig Technologies Appoints Jay Millerhagen as Vice President, Clinical Affairs

BioSig Technologies, Inc. announced Jay Millerhagen has been appointed Vice President, Clinical Affairs. Mr. Millerhagen has over 25 years of experience developing, evaluating and launching new medical technologies and therapies. Most recently, Mr. Millerhagen served as Vice President, Clinical Affairs and Market Development for RESPICARDIA, Inc., in Minnetonka, MN. At RESPICARIDIA, he led clinical operations, staffing and site management leading to the pivotal IDE trial of the fully implantable remedÄ" System for the treatment of Central Sleep Apnea.

Jeffrey F. O'Donnell Rejoins BioSig Technologies' Board of Directors

BioSig Technologies announced Jeffrey F. O'Donnell, Sr. has rejoined BioSig's Board of Directors and will serve as Chairman of the Compensation Committee. Mr. O'Donnell sat on BioSig's Board of Directors from October 2011 through February 2014. Currently, Mr. O'Donnell serves as CEO and Chairman of the Board of privately-held Trice Medical.

Similar Private Companies By Industry

Company Name Region
Sizewise Rentals, LLC United States
VuCOMP, Inc. United States
Omni Surgical LP United States
Collagen Matrix, Inc. United States
Electroblate, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
Private Placement
December 19, 2014
--
Private Placement
August 15, 2014
--
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BioSig Technologies, Inc., please visit www.biosigtech.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.